These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 12861895)

  • 1. How abnormal calcium, phosphate, and parathyroid hormone relate to cardiovascular disease.
    Bro S
    Nephrol Nurs J; 2003 Jun; 30(3):275-81; quiz 282-3. PubMed ID: 12861895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
    Slinin Y; Foley RN; Collins AJ
    J Am Soc Nephrol; 2005 Jun; 16(6):1788-93. PubMed ID: 15814832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary hyperparathyroidism is associated with higher cost of care among chronic kidney disease patients with cardiovascular comorbidities.
    Khan S
    Nephron Clin Pract; 2007; 105(4):c159-64. PubMed ID: 17259740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular system in patients in different stages of chronic kidney disease].
    Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
    Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral metabolism disturbances in patients with chronic kidney disease.
    Kestenbaum B; Belozeroff V
    Eur J Clin Invest; 2007 Aug; 37(8):607-22. PubMed ID: 17635571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial texture and cardiac calcification in uremia.
    Wade MR; Chen YJ; Soliman M; Kaptein E; Massry SG; Rahimtoola SH; Chandraratna PA
    Miner Electrolyte Metab; 1993; 19(1):21-4. PubMed ID: 8345830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L; Marco MP; Martínez I; Rue M; Borràs M; Martín ML; Sarró F; Valdivielso JM; Fernández E
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)].
    Portolés J; López-Gómez JM; Aljama P
    Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and treatment of CKD patients before and at their first nephrologist encounter in Canada.
    Curtis BM; Barrett BJ; Djurdjev O; Singer J; Levin A
    Am J Kidney Dis; 2007 Nov; 50(5):733-42. PubMed ID: 17954286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the pre-transplant bone-mineral metabolism do not affect the initial progress of the renal graft].
    Rodrigo Calabia E; Ruiz San Millán JC; Gago M; Ruiz Criado J; Piñera Haces C; Fernández Fresnedo G; Palomar R; Gómez Alamillo C; Martín de Francisco AL; Arias M
    Nefrologia; 2009; 29(2):143-9. PubMed ID: 19396320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?
    Coen G; Manni M; Mantella D; Pierantozzi A; Balducci A; Condò S; DiGiulio S; Yancovic L; Lippi B; Manca S; Morosetti M; Pellegrino L; Simonetti G; Gallucci MT; Splendiani G
    Nephrol Dial Transplant; 2007 Nov; 22(11):3262-7. PubMed ID: 17597083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
    Bignelli AT; Barberato SH; Aveles P; Abensur H; Pecoits-Filho R
    Blood Purif; 2007; 25(3):233-41. PubMed ID: 17377377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in mineral metabolism: Kidney Early Evaluation Program (KEEP) and the National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Vassalotti JA; Uribarri J; Chen SC; Li S; Wang C; Collins AJ; Calvo MS; Whaley-Connell AT; McCullough PA; Norris KC;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S56-68. PubMed ID: 18359409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of progressive vascular calcification in haemodialysis patients.
    Chertow GM; Raggi P; Chasan-Taber S; Bommer J; Holzer H; Burke SK
    Nephrol Dial Transplant; 2004 Jun; 19(6):1489-96. PubMed ID: 15102961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
    Olauson H; Qureshi AR; Miyamoto T; Barany P; Heimburger O; Lindholm B; Stenvinkel P; Larsson TE
    Nephrol Dial Transplant; 2010 Sep; 25(9):3033-8. PubMed ID: 20368304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation between serum calcium, phosphate, parathyroid hormone and 'nondipper' circadian blood pressure variability profile in patients with normal renal function.
    Kanbay M; Isik B; Akcay A; Ozkara A; Karakurt F; Turgut F; Alkan R; Uz E; Bavbek N; Yigitoglu R; Covic A
    Am J Nephrol; 2007; 27(5):516-21. PubMed ID: 17703091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.